LifeMD, Inc. (LFMDP) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of LifeMD, Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LFMDP
LifeMD, Inc.
$23.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LFMDP vs TARA
growth of $100 · dividends reinvested · last 5yLFMDP +67.0% (+10.8%/yr)TARA -62.2% (-17.7%/yr)LFMDP compounded faster over this window
LFMDP TARA
LFMDP vs TARA: by the numbers
- •LFMDP is the larger company ($159M vs $144M market cap).
- •Both run net losses; TARA's is the smaller (0.00% vs -10.40% net margin).
- •LFMDP pays a dividend (9.71% yield), while TARA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LFMDP | TARA |
|---|---|---|
| P/S ratio | 0.78 | N/A |
| P/B ratio | 19.99 | 0.89 |
Profitability
| Metric | LFMDP | TARA |
|---|---|---|
| Gross margin | 85.91% | 0.00% |
| Operating margin | -9.35% | 0.00% |
| Net margin | -10.40% | 0.00% |
| ROE | -266.86% | -43.40% |
| ROIC | -143.97% | -47.18% |
Dividends
| Metric | LFMDP | TARA |
|---|---|---|
| Dividend yield | 9.71% | N/A |
Growth (annualized)
| Metric | LFMDP | TARA |
|---|---|---|
| Revenue CAGR (5Y) | 26.00% | N/A |
| Total return CAGR (5Y) | 10.80% | -16.45% |
Frequently asked
- Does LFMDP or TARA pay a bigger dividend?
- LFMDP pays a dividend (9.71% yield), while TARA has no payments in the available dividend history.
- How have LFMDP and TARA total returns compared?
- Over the past 5 years, LFMDP delivered 10.80% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LifeMD dividend yieldLifeMD ROEProtara Therapeutics ROELifeMD operating marginProtara Therapeutics operating marginLifeMD revenue growthProtara Therapeutics revenue growthLifeMD free cash flowProtara Therapeutics free cash flow
LifeMD & Protara Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.